g-heregulin is a recently described novel isoform of the heregulin/neuregulin class of EGF-like ligands that bind to and activate receptors of the ErbB family. Deregulated signaling through the heregulin-ErbB pathway is thought to be implicated in the development of a subset of human breast cancers. g-heregulin has been found to be expressed in the culture supernatant of MDA-MB-175, a breast carcinoma cell line. g-heregulin is characterized by the presence of a large N-terminal peptide extension that is not found in other heregulin isoforms. Here we report that this unique N-terminal extension of g-heregulin is identical to the N-terminus of DOC4, a product of a recently identi®ed CHOPdependent stress-induced gene. Human DOC4 and the heregulin-encoding genes map to dierent chromosomes and the MDA-MB-175 cell line contains a chromosomal translocation that leads to the fusion of DOC4 and HGL, on chromosomes 11 and 8, respectively. Thus, gheregulin is a product of a mutant fusion gene and not a bona ®de normal isoform. We speculate that the mutation may be selected for by virtue of its ability to activate ErbB signaling through the production of an autocrine ligand.
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Keywords: signal transduction; EGF receptor; tyrosine kinase; tenascin; CHOP Heregulins (or neuregulins) are a group of soluble and cell-membrane bound EGF-like peptide ligands that signal through a related class of tyrosine kinase receptors belonging to the ERBB family and are encoded by three distinct genes (Burden and Yarden, 1997) . Deregulated signaling through the heregulinErbB pathway is thought to play a role in the development of a subset of human breast cancers (reviewed in Lupu et al., 1996; Normanno et al., 1994) . This has generated a substantial interest in identifying and characterizing the genes and proteins involved in this pathway.
g-heregulin is a novel heregulin isoform that was identi®ed in the culture supernatant of MDA-MB-175, a human breast carcinoma cell line (Schaefer et al., 1997) . Cloning of the g-heregulin cDNA revealed its C-terminus to be identical to previously characterized heregulin isoforms encoded by the HGL/NRG1 gene. However, its N-terminal predicted peptide sequence is unrelated to any known heregulin. It was suggested that g-heregulin is a novel splicing variant of the HGL gene. We have recently cloned DOC4, a gene that is induced during cellular stress (Wang et al., 1998) . DOC4 encodes a large secreted protein that is related to Drosophila Tenm, a protein that plays a critical role in early¯y development (Baumgartner et al., 1994; Levine et al., 1994) . Comparison of the predicted peptide sequence of DOC4 to other known proteins revealed complete sequence identity between its Nterminus and the novel portion of g-heregulin. Cterminal to this region of identity, the two proteins are completely dissimilar (Figure 1 ). This alignment is consistent with two possibilities: either g-heregulin and DOC4 represent alternatively processed products of the same gene or g-heregulin is a product of a translocation that fuses two dierent genes (DOC4 and HGL). Here we present data supporting the latter explanation.
We determined the chromosomal location of human DOC4 and con®rmed the address of human HGL. DOC4 mapped to band q13 on human chromosome 11. This result was obtained by both radiation hybrid mapping on the GeneBridge 4 panel and by FISH analysis using YAC 803D7 that contains the DOC4 gene (Figure 2a and b). The YAC was isolated from the CEPH libraries (Centre d'Etudes du Polymorphisme Humain, Paris, France). HGL's location at band p12 of chromosome 8 was con®rmed by the same two criteria (Figure 2a and c) . Next we performed dual channel FISH analysis using HGL and DOC4 speci®c YAC probes, that had been labeled with dierent uorochromes as previously described . Overlapping DOC4 and HGL signals were identi®ed on the two 8;11 derivative chromosomes present in the aneuploid MDA-MB-175 cells ( Figure  2c ) but not in any other cell tested (not shown). The karyotype of MDA-MB-175 cell line is hypotetraploid, modal number: 89, with complex chromosomal rearrangements that include several alterations in chromosomes 8 and 11: 78, der(8;11)t(8;11) (?p11;q13)?dup(11)(q13)ins(11;8)(q11;?)62 (see the magni®ed views of the normal and rearranged chromosomes in Figure 2c ). It is of interest to note that the initial karyotype of MDA-MB-175 cell line contained a description of a marker chromosome likely to be the result of a t(8;11) translocation (Cailleau et al., 1974) . We conclude that g-heregulin is a product of a translocation, t(8;11), that fuses the 5' end of DOC4 to HGL.
g-heregulin, puri®ed from culture supernatants of MDA-MB-175, cells serves as an activating ligand for the ErbB3-ErbB2 receptor complex of MCF-7 breast carcinoma cells (Schaefer et al., 1997) . Furthermore, Erb2 levels are four to six times higher in the MDA-MB-175 cells than in normal breast epithelium and the ErbB3-ErbB2 receptor complex is constitutively phosphorylated in these cells. These observations led Schaefer et al. (1997) to propose that g-heregulin is an autocrine growth factor for the MDA-MB-175 cells.
Peptide sequence analysis of g-heregulin puri®ed from cell culture supernatant, reveals that the mature form results from cleavage within the DOC4 portion of the fusion protein, at glycine 519 of the predicted precursor protein (G Schaefer and M Sliwkowski personal communication). DOC4 is a secreted protein that is expressed at high levels in certain cell types Figure 1 Schematic alignment of the peptide sequence of b-heregulin (top), g-heregulin (middle) and DOC4 (bottom). The vertical lines indicate regions of sequence identity between the C-terminus of b-heregulin and g-heregulin and the N-terminus of g-heregulin and DOC4.`Ig', immunoglobulin homology,`ERG', epidermal growth factor homology domains of heregulin Figure 2 Chromosomal localization of DOC4, HGL and the fusion gene present in the MDA-MB-175 cell line. (a) Placement of DOC4 (left) and HGL (right) on the frame-work of the GeneBridge 4 radiation hybrid map. The location of the two genes is indicated by the arrows. Mapping of DOC4 on the GeneBridge 4 radiation hybrid panel was performed using human-speci®c primer pairs that recognize a region in the 3' untranslated region. Primer A: ATTCACCCAACACCAGAATCC, primer B: TGGTTCCAGACTTCAGGAAAATG. PCR conditions: 948C (4''), [948C(45'), 608C(45'), 728C(35')]X35, 728C(10'') in a buer containing 1.5 mM MGCl 2 . The length of the ampli®ed segment is 166 base-pairs. The`vector' obtained: 10010 00001 10001 10101 00100 10110 00000 10000 01011 11000 11100 00001 00001 00001 00010 00000 01001 00000 001. Mapping of HGL was performed using the primer pairs: HER21.11.1S and HER21.11.5AS as previously described (Lee and Wood, 1993) . The vector obtained: 00010 10101 00100 00000 00011 10120 01001 00010 01010 11200 10000 00100 01100 10110 10111 01100 11010 00000 110.
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DOC4-HGL fusion protein in MDA-MB-175 X-Z Wang et al (Wang et al., 1998) . Collectively these ®ndings suggest that the expression of the DOC4-HGL fusion gene is selected for by virtue of its ability to encode a soluble activating ligand of the ErbB3-ErbB2 receptor complex. According to this model, DOC4 contributes highlevel expression of the fusion gene as well as signals (b) Chromosomal localization of DOC4 by FISH using biotinylated total yeast DNA from YAC 803D7 on metaphase spreads of normal human lymphocytes. A green hybridization signal is observed on the two normal chromosomes 11, band q13 (left panel). The same spread, counter-stained blue with 4',6-diamidino-2-phenylindole dihydrochloride (DAPI) and image processed with a sharpen ®lter to increase the chromosome banding resolution is shown in the right panel. Magni®ed views of isolated chromosomes 11 are shown at the bottom. (c) Left panel: Dual channel FISH analysis of a representative MDA-MB-175 metaphase spread using biotinylated DOC4 YAC 803D7 and digoxigenin labeled HGL YAC 978B9 . Green signals from YAC 803D7 (DOC4) are seen on normal 11 and der(8;11) chromosomes. Red signals from YAC 978B9 (HGL) are seen on normal chromosomes 8 and on the rearranged chromosomes der(8;11). The rearranged chromosome, der(8;11), also contains a yellow overlay of the two signals. Magni®ed views of isolated chromosomes 8, 11 and der(8;11) are shown at the bottom of the panel. Lupu et al., 1996) and expression of a DOC4-heregulin fusion protein would presumably constitute a means of activating this growth pathway in an autocrine or paracrine manner. We surveyed 89 breast carcinoma samples for the expression of g-heregulin (DOC4-heregulin) by RT ± PCR. These included ductal, lobular, medullary, and mucinous histological types collected at the Institute Paoli Calmettes (a gift from Dr J Jacquemier, Marseille, France) and 18 primary and 18 lymph node metastases of human breast cancers from the NYU tissue bank. The DOC4-HGL fusion transcript (g-heregulin) was detected by RT ± PCR using primers based on the sequence between nucleotides 1933 and 2261 of the published g-heregulin sequence. Primer A (DOC4.9S): TTG GAT TCA GGA ATC TGG CAC, Primer B (HGL1.2AS): CTG ATC ACT TTG CAC ATA TAC TC; PCR conditions: 948C(3); [948C(30'')?528C(30'')?728C(30'')]X35; 728C (10'), in 2 mM MgSO 4 , 67 mM Tris (pH=8.0), 16 mM (NH4)2SO 4 , 33 mg/ml BSA, 200 mM dNTPs. A fusion transcript was not detected in any of these samples. Transcript was not detected in any of the other breast cancer cell lines we studied (MDA-MB-134, 231, 453, MCF-7, T-47D and ZR-75-1, obtained from the American Typed Culture Collection, Rockville MD, USA). RNA from the MDA-MB-175 cell line served as a positive control in this analysis (data not shown). We conclude that g-heregulin is the product of a rare gene fusion event between DOC4 and HGL and that the chromosomal translocation that gave rise to this event is not commonly observed in human breast cancer samples. However, because of the compelling theoretical mechanism that would drive positive selection for breast cancer cells that acquire a DOC4-HGL fusion, it is worth examining a large number of ErbB2 overexpressing tumors for the presence of this somatic mutation.
